NSC |
Compound |
Enrichment |
Correlation |
NSC 740602 |
Null |
0.0339770934764508 |
0.22775953 |
NSC 744025 |
diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate |
0.0339770934764508 |
0.2495857 |
NSC 749292 |
3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine |
0.0339770934764508 |
0.3274527 |
NSC 749550 |
3-amino-N-(4-benzylphenyl)-5-chloro-1H-indazole-1-carboxamide |
0.0339770934764508 |
0.3474107 |
NSC 756304 |
GW678313X |
0.0339770934764508 |
-0.059320115 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0339770934764508 |
0.33948882 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0339770934764516 |
0.28150216 |
NSC 205555 |
Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- |
0.0339770934764516 |
0.24732496 |
NSC 291330 |
Null |
0.0339770934764516 |
0.12056474 |
NSC 295641 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.0339770934764516 |
0.09093899 |